Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholecystolithiasis × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 NET 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Neuroendocrine Tumors 484 Gastro-enteropancreatic neuroendocrine tumor 53 Carcinoid Tumor 50 Neoplasms 44 Carcinoma, Neuroendocrine 37 Pancreatic Neoplasms 31 Adenoma, Islet Cell 30 Neoplasm Metastasis 25 Pheochromocytoma 22 Colorectal Neoplasms 22 Paraganglioma 21 Stomach Neoplasms 20 Carcinoma, Hepatocellular 20 Carcinoma 18 Breast Neoplasms 18 Prostatic Neoplasms 17 Gastrointestinal Neoplasms 17 Thyroid Neoplasms 16 Sarcoma 16 Lung Neoplasms 15 Neuroblastoma 13 Serotonin Syndrome 12 Esophageal Neoplasms 12 Cholangiocarcinoma 12 Melanoma 11 Colonic Neoplasms 11 Small Cell Lung Carcinoma 10 Digestive System Neoplasms 10 Carcinoma, Renal Cell 10 Carcinoma, Non-Small-Cell Lung 10

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡